US Multiple Myeloma Drugs Market Analysis


  • Type: Oncology area
  • Published : March 2021
  • Region: North America
  • Country: US
  • Report ID : 183

  • Format: PPT, PDF

Us Multiple Melanoma Market And Trends Analysis And Forecast 2019-2028

SKU: 183 Categories: ,

Report Overview

The U.S Multiple Myeloma drugs market size stood at USD 5.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Multiple myeloma is a rare form of cancer that has a direct impact on the blood in the human body. Because of blood disorders, there has been a huge emphasis on the development of drugs associated with the treatment of the disease. The increasing investment in the R&D of products by large scale companies across the world will bode well for the market in recent years. Advances in ongoing clinical trials associated with the treatment of the disease, will open a huge potential for the companies operating in the market. The presence of several large-scale companies will bode well for the market in the foreseeable future.

Market Drivers

Significant developments in the healthcare sector, along with the increasing prevalence of haematological cancer, is one of the key factors driving the growth of the market. Multiple myeloma is usually caused by specific genetic abnormalities, and the treatment of this disease involves drugs that modulate the immune system and aid in enhancing the efficiency of chemotherapies, radiation therapies, stem cell transplants and platelet transfusion.

Furthermore, rising consumer awareness regarding the benefits of biologic therapy drugs, which utilize the body’s immune system to identify and attack the myeloma cells, is also providing a boost to the market growth. Additionally, various technological advancements, such as the development of microRNA therapeutics and nanomedicines for the treatment of multiple myeloma, is acting as another growth-inducing factor. These medicines are used to facilitate the delivery of macromolecular agents into the bone marrow and catalyse antitumor responses. Other factors, including the rising healthcare expenditures and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

  1. U.S Multiple Myeloma Drugs Market Overview…………..……………………………..
    1. Market Size
  2. Market Growth Drivers……………………………………………………..……………….
    1. Rise in Prevalence of Multiple Myeloma in U.S
    2. Growing R&D Investments and Reimbursement Policies
  3. Major Types of Multiple Myeloma….……………….…………………………..….………
    1. Hodgkin’s Lymphoma
    2. Non-Hodgkin’s Lymphoma
  4. Multiple Myeloma Drugs Market Segmentation…….…..………….…………….……..
    1. Treatment Therapeutics:
      1. Chemotherapy
      2. Immunotherapy
      3. Radiotherapy
      4. Targeted Therapy
      5. Others
    2. Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  5. Multiple Myeloma Drugs Market Share……………..…………..……..…………………
    1. Market Analysis, Insights and Forecast – By Revenue
  6. Competitive Landscape………………………………………………………………………
    1. Major Players
    2. Products in Pipeline
  7. Key Company Profiles……………………………………………………………
    1. Janssen Biotech Company Product & Services, Strategies & Financials
    2. Celgene Corporation Product & Services, Strategies & Financials
    3. Novartis Company, Product & Services, Strategies & Financials
  8. Healthcare Policies and Regulatory Landscape……………………..……..……….…
    1. Policy changes and Reimbursement scenario
  9. Factors Driving Future Growth……………………………………………………………
    1. New Trends and Development of Multiple Myeloma Drugs Market
    2. Future Opportunities
  10. Conclusion

Market Segmentation

By Treatment Therapeutics:

Chemotherapy and other drugs segment dominated the segment with the largest revenue share. Unavailability of alternatives and limitations of surgical procedures are the factors driving the focus of oncologists toward chemotherapy for treating multiple myeloma. Several pipeline drugs undergoing phase III clinical trials with positive clinical outcomes are expected to engender a surge in the industry growth upon the launch of these novel drugs during the forecast period.

Stem cell transplant and radiation therapies include the first line therapy for multiple myeloma. However, the associated demerits including complications in stem cell transplant procedures and limited applications of radiation methods are driving the oncologist’s preference towards multi-therapy regimens, which include combination of chemotherapy, radiation, and other supportive treatments based on patient response and symptoms.

Immunomodulation agents dominated the chemotherapy and other drugs segment, while the monoclonal antibodies segment is expected to grow at the fastest CAGR. The chemotherapy and other drugs segment include traditional chemotherapy, immunomodulating agents, proteasome inhibitors, Histone deacetylase (HDAC) inhibitors, and monoclonal antibodies. Immunomodulating agents currently dominated the segment by capturing majority of the industry share.

By Distribution Channel:

Based on the distribution channel, the market has been segregated into hospitals, retail, online and other pharmacies.

Major Players

The multiple myeloma therapeutics is a consolidated market. Celgene Corporation accounts for a large company share with its high revenue generating drugs, Revlimid and Pomalyst. Other major players include Janssen Biotech, Inc., Bristol-Myers Squibb Company, Novartis AG, Millennium Pharmaceuticals, Amgen, Inc., Genzyme Corporation, and Juno Therapeutics. Most of the companies are focusing on developing combination drug therapies along with the development of new drugs.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements